Dr. James O. Armitage, MD

Dr. Armitage practices at Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System.

Dr. Armitage's NPI, 1073579090, was assigned on April 26, 2006. Dr. Armitage graduated from University of Nebraska College of Medicine in 1973. Dr. Armitage holds Nebraska license 12643.

Dr. Armitage's primary practice is Nebraska Medical Center, at 988102 Nebrasks Medical Center, Omaha, NE 68198 in Douglas County. The practice phone is (402) 559-4000. Dr. Armitage also practices at Nebraska Medical Center, 987400 Nebraska Medical Ctr, Omaha, NE 68198.

Dr. Armitage's primary practice is Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System. The medical group on file is UNMC Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Armitage practices. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Armitage's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Armitage is licensed in Nebraska.

CMS data shows 142 Medicare services from Dr. Armitage across 2 procedure codes in 2024, all of them office visits, for 74 Medicare patients. Medicare paid $9,459 for them. Every service was in an office.

CMS counts 74 Medicare patients who saw Dr. Armitage in 2024. The largest group is 65 to 74, with 39 patients. 75% of them have high cholesterol, and 73% have high blood pressure. Their average risk score is 1.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Armitage's median patient age at 71, with 44% women.

In 2024, Dr. Armitage wrote 248 Medicare Part D claims for 29 patients. 61% of them were for generic drugs. CMS names the drug for 193 of them, across 11 drugs with 11 or more claims each, at $1,209,254 in total drug cost. In 2023, CMS named 62 claims across 4 drugs.

Dr. Armitage accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 150 papers to Dr. Armitage, published from 2010 to 2025. 2015 was the busiest year, with 19. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Lymphoma, Large B-Cell, Diffuse and Hematopoietic Stem Cell Transplantation. Dr. Armitage has published most often in Clin Lymphoma Myeloma Leuk. Dr. Armitage's most frequent co-authors are Vijaya Raj Bhatt, MD, Dennis D. Weisenburger, MD and Dan L. Longo, MD.

CMS Open Payments shows 81 general payments to Dr. Armitage from 8 drug and device companies from 2016 to 2024. Ownership or investment make up the largest share, 92% of the total. TESARO, Inc. paid the most, $1,855,192.

Dr. Armitage graduated from University of Nebraska College of Medicine in 1973.